Will generic supply of bedaquiline be accessible? Subject: Science and technology Section: Health Context: Bedaquiline has now become the cornerstone to cure drug-resistant tuberculosis (DR-TB). Details: Johnson & Johnson’s patent on bedaquiline expired on July 18. This expiry will allow generic manufacturers to supply the drug. J&J has filed secondary patents over bedaquiline […]